COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,537 Articles (22,881 medRxiv, 8,656 bioRxiv)

Most recent first Previous |  Page 30: Articles 291-300  | Next

Bio-Rad and QIAGEN digital PCR platforms provide equivalent quantification for wastewater-based SARS-CoV-2 surveillance
Clerkin, T., Smith, S., Zhu, K., Blackwood, D., Gallard-Gongora, J., Capone, D., Brown, J., Noble, R. T.
10.64898/2026.01.20.26344437 — Posted: 2026-01-22
Association of mRNA COVID-19 vaccination with overall survival in patients receiving immune checkpoint inhibitors: a retrospective cohort analysis.
Cheng, M. T., Keen, J. L., Frost, S., Favara, D. M.
10.64898/2026.01.19.26344403 — Posted: 2026-01-22
Radiological phenotyping in COVID-19 Acute Respiratory Distress Syndrome: a secondary analysis of a retrospective cohort study
Joseph, A., Ricard, J.-D., de Margerie-Mellon, C., Walter, T.
10.64898/2026.01.21.26344520 — Posted: 2026-01-22
Rising vaccine hesitancy in a future pandemic after COVID-19 and its decision drivers in Japan
Kawasaki, J., Hamada, M., Machida, M., Komorizono, R., Kobayashi-Ishihara, M., Fujita, N., Tabuchi, T., Furuse, Y.
10.64898/2026.01.18.26344375 — Posted: 2026-01-21
Optimizing broadly neutralizing antibodies via all-atom interaction modeling and pre-trained language models
Song, Y., Wu, F., Wang, R., He, B., Yan, Q., Huang, X., Chen, S., Yuan, Q., Rao, J., Tang, Z., He, H., Zhao, J., Yang, Y., Yao, J.
10.64898/2026.01.20.700456 — Posted: 2026-01-21
Nevermore: Target-Conditioned Protein-Ligand Representation Learning for Multi-Objective Lead Optimization with Database-Grounded Retrieval
Refahi, M. S., Toutounchian, M., Sokhansanj, B., Yoo, H., Brown, J. R., Ji, H.-F., Rosen, G.
10.64898/2026.01.20.700610 — Posted: 2026-01-21
A {lambda} Phage Platform for Successful Therapeutic Display of Protein Antigens
Bush, M. S., Li, X., Rajaure, M., Court, D. L., Adhya, S.
10.64898/2026.01.19.700330 — Posted: 2026-01-21
SARS-CoV-2 membrane protein biogenesis
Ortiz Mateu, J., Pearson, G. J., Rius-Salvador, M., Sedighian, S., Pavlova, A., Alonso-Romero, J., Acosta-Caceres, J. M., Metola, A., Garcia-Murria, M. J., Skehel, J. M., Gumbart, J. C., Carlton, J. C., von Heijne, G., Sanchez-del Pino, M. M., Martinez-Gil, L., Mingarro, I.
10.64898/2026.01.19.700281 — Posted: 2026-01-20
Synthetic RNA-protein decoy granules to prevent SARS-CoV-2 infection
Willinger, O., Granik, N., Salomon, T., Goldberg, S., Amit, R.
10.64898/2026.01.16.699918 — Posted: 2026-01-19
Ultra-deep sequencing reveals intra-host diversity and co-infection-driven evolution of SARS-CoV-2
Moraga, C., Francisco Kirhman, F., Bernal, B., Poblete, S., Jullian, P., Gonzalez, A., Latorre, M., Di Genova, A.
10.64898/2026.01.15.699801 — Posted: 2026-01-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).